Disclosure

Tintellectual
he following presentation, information and content is
property and confidential material of
Ananda Pharma SAS.
� The public execution of this proposal in a partial or
general manner, will have to be previously and expressly
authorized by A n a n d a P h a r m a S A S .

All rights reserved 2019

COLOMBIA
2 About
Us

We sow
collect & ANANDA PHARMA SAS
Colombian company

transform Created with national capital and a

multidisciplinary human team who is
passionate about medicinal cannabis. Its
main objective is to further advance the
cannabis industry in a responsible manner
through the use of science and technology.
M I SSI ON Additionally, ANANDA PHARMA SAS complies

To satisfy the needs of the cannabis industry

through the acquisition, commercialization
of seeds and high quality resins which are
obtained by standardized processes, making
us a reference in the world of cannabis.

VI SSI ON
To become a highly positioned company in the
global cannabis market that is recognized by
its outstanding product and its social
commitment.
with high standards of quality throughout
the whole process, from the selection
of seeds to commercialization, conforming
with the Colombian regulation.
 Our
3 Team

C arlos
Nuñez
PhD (Medicine)
Epidemiologist.
A lexander Rippe
Industrial microbiologist - master's
degree in innovation and MBA
Research and development manager
our
team
for foods Middle Americas at Unilever.
Masters of public health. Marketing Director at Ananda Pharma
SAS.

L
uis Eduardo Nuñez
Miranda
Internatioal business advisor
International Busines Advisor.
B eatriz Pacheco /
Alexander Espitia
Businessmen Farmers, Growers
Land Partners Ananda Pharma SAS.
C amilo
Salgado
Architect - Piloted Commercial

Founder of Salgado Restrepo

Constructor.
Director of design and construction
Ananda Pharma SAS.

R ocio
Carrascal
Professional Technologist in
International Trade
W
ilson Tascon
Salazar
Canon Lawyer Theologian

Business Advisor specialized in: Business Advisor in State Tenders.

Technical Standards, Sanitrary Manager of Comercializadora Elielo and
Registry and Customs Regulations. member of Ananda Pharma SAS.
Legislation and Integral Regulations in
Medicinal Cannabis.
3 4WhyWhy
Colombia
Colombia Why
01 Colombia?
Variety of ecosystems
that enables the year
long farming

02
Low cost and high
quality labor
03
Strategic geographical
location
04
Stable environment
located along the Equator

05
Most complete regulation
in the World
06
Optimal radiation levels
for 12/12 hours of
daylight year round
 Why 5 Why
Boyacá-Pesca

Boyacá-Pesca? Alberto Lleras

Recognized place in Colombia for Camargo Airport
mongui
promoting the cultivation, sowing IATA: sox
firavitoba OACI: skso
and harvesting of cannabis.
sogamoso Pesca
iza 22km/13.7 miles
distance
cuitiva

pesca
tota

aquitania
Boyacá
Colombia

12 hours a day, all year round.

“Pueblo del Sol” or “The Sun’s Town”.
Altitude of 2,540 to 4,000
metres above sea level (MASL).
Population: 8250 approx.
Safe place.
 Our
6 Land

Our
Land

|
XX

XX
| |
XX

XX
| XX
|
XX|
XX|
℗
XX|
XX
|
XX|
|
XX
XX
| ℗
XX|
℗ XX|
XX
|

XX| XX
|

XX|

℗ XX|
XX
|
XX|
XX| XX|
XX| XX| XX|
XX|
XX| XX| XX|
XX|
XX|
XX|

XX|

XX|
XX|

XX|
We sow

XX|

XX|
XX|

XX|
℗

XX|

XX|
XX|

XX|
XX|
collect

XX|
℗
XX|

XX|

℗
XX|

XX
|
XX|

XX|
XX|

XX|
transform

℗
XX|
XX|

XX|
XX|

XX|
XX|

XX|
|
XX

XX|

XX|

XX|
XX|

XX|

XX|

XX|
XX|

XX|
XX|
XX|
XX|

XX|
XX|
XX|
XX|

℗
XX|
XX|

℗
XX|

XX|
XX|

XX|

XX|

XX|

XX|
XX|

XX|

XX|

XX|

XX|
XX|

AREA TOTAL:
XX|

XX|
XX|

XX
19500.2 m²
XX|

|
XX|
XX|
XX|
XX|

XX
XX|

|
XX|
XX|

℗
XX|
XX|

XX
|
℗
 Legal
Framework

Psychoactive
framework Cultivation
Non-Psychoactive
Ministry of Justice
Psychoactive
Processing
Non-Psychoactive

ICA
(Colombian Agro Institute) Strain Registration
legal

INVIMA
(Colombian FDA)

In the legal field it is *Intention to get when gray areas get

necessary to indicate three resolved
main parts, for the industry * Will get when processing
development. plant is built
 Medicinal
8 Cannabis

Seeds commercialization
Health belongs Department
to everyone of Health
Seed source
Seeds: 700 Units approx
Agronomic
evaluation test
Costs of registering Phase 1
Cuttings: 60 Units with ICA
Process and procedure
Industrialization of crop standardization
Chain
of Medicinal
Cannabis
Requieres license of cultivation

Requires license of transformation

Quality processes
Requires license of psychoactive
and raw material Phase 2
Standardized standardization
cannabis Commersialization stage
Cannabis Oil

Our
Process Harvest with good
Phase 3 agricultural practices
 Medicinal
9 Cannabis

Our
Process
Seeds commercialization
t

Seed source Agronomic

Seeds: 700 Units approx Costs of registering
evaluation test with ICA
Cuttings: 60 Units
Process and procedure
n of crop standardization

ion
Phase 1 Quality processes
e cannabis Phase 2
and raw material
Standardised
requires a capital investment of US $791.700
standardisation
This phase
Cannabis Oil
 Process and procedure
on of crop standardisation Medicinal
10 Cannabis

Our
Process
Phase 2
tion

Quality processes
e cannabis
and raw material
Standardized standardization
Cannabis Oil

r
s Harvest with good
agricultural practices

Phase 3
This phase requires a capital investment of US $43.300
 Production
11 Plan

TOTAL AREA OF SOWING (1st year): 5 Ha

The estimated production is based on data of Production
Plan
distribution of an adult female cannabis plant
of 601g of mass in total:

Flowers

26,27% 157.9g
Foliage
ANANDA PHARMA SAS
25,05% 150.5g Colombian company
Has a high commitment to produce a
Stems and branches premium product that will be the result of

33.69% 202.5g the highest quality standards during the

industrialization of medical cannabis.

Root

14.99% 90.1g
Assuming a distribution of 8,000 plants per
hectare (two harvest per year), 4,000 kg of flower
produced per hectare per year will be obtained
 Production
1 Plan

Estimated production of cannabis oil

in an agronomic evaluation
unit for one year

CONCEPT UNIT TOTAL

Sowing Area in mt² 1 480

Number of Plants mt² 1,25 600,000

Quantity of production in grams (250 grs / plant on average) 250 150.000,00

Quantity of 500 grs lots of dry flowers 1 300,00

Amount of Oil Production in milliliters (60mls / 500 grs dry matter) 18.000,00

* Estimated data, the real data will be taken after the agronomic evaluation units have been completed
1 Costs

Acquisition of mother plants and standardized

dry matter
Includes: administrative expenses + seed source
+ agronomic assessment.

USD $0.17

Obtention of subsequent dry matter

Includes: administrative expenses

USD $0.011 Attainment of standardized cannabis resin

Cost per millilitre of resin
Farm costs
USD $0.19
6

USD $0.16 Laboratory administrative costs

Cost per millilitre of resin
USD $1.60

Unforeseen expenses

Costs USD $0.46

Total cost
Execution of the agronomic test
Cost
USD $2.69